Provided by Tiger Trade Technology Pte. Ltd.

Arbutus Biopharma

4.56
-0.2200-4.60%
Post-market: 4.750.1920+4.21%16:32 EDT
Volume:16.12M
Turnover:74.50M
Market Cap:898.04M
PE:5.78
High:4.78
Open:4.77
Low:4.51
Close:4.78
52wk High:5.45
52wk Low:3.50
Shares:196.94M
Float Shares:123.00M
Volume Ratio:1.16
T/O Rate:13.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7896
EPS(LYR):-0.1748
ROE:89.58%
ROA:48.84%
PB:3.47
PE(LYR):-26.08

Loading ...

Atea Pharmaceuticals Q2 Loss Narrows as HCV Trial Expenses Decline

Reuters
·
Aug 13

Arbutus Q2 FY26 Net Loss Widens to $5.1 Million; Revenue Drops 90.56% to $1.01 Million

Reuters
·
Aug 12

Arbutus Biopharma Q2 EPS $(0.03) Misses $(0.02) Estimate, Sales $1.014M Beat $700.000K Estimate

Benzinga Earnings
·
Aug 12

Earnings Flash (ABUS) Arbutus Biopharma Posts Q2 Loss $0.03 a Share, vs. FactSet Est of $0.02 Loss

MT Newswires Live
·
Aug 12

Arbutus Biopharma Q2 Revenue USD 1 Million

THOMSON REUTERS
·
Aug 12

Arbutus Reports Second Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
Aug 12

Arbutus Biopharma Corp Expected to Post a Loss of 2 Cents a Share - Earnings Preview

Reuters
·
Jul 31

Arbutus Biopharma Reshapes Strategy After Moderna Settlement

TIPRANKS
·
Jul 17

Arbutus Biopharma, Genevant sue Pfizer, BioNTech Over Lipid Nanoparticle Patents

MT Newswires Live
·
Jul 16

Arbutus Files Patent Infringement Suits Against Pfizer, Biontech over LNP Technology

Reuters
·
Jul 16

Arbutus Biopharma Corp - Anticipates Receipt of Dividend from Genevant in Q3 2026

THOMSON REUTERS
·
Jul 16

Arbutus Biopharma Corp - Co and Genevant File Lawsuit in Canada Seeking Injunction and Damages Against Pfizer/biontech

THOMSON REUTERS
·
Jul 16

Arbutus Biopharma Corp - Expects to Return up to $230 Mln in Capital to Shareholders

THOMSON REUTERS
·
Jul 16

Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and Biontech, Receives First Payment from Moderna Settlement Agreement and Announces Intent to Return Capital to Shareholders

THOMSON REUTERS
·
Jul 16

Arbutus Biopharma Corp - Receives About $178 Mln from Moderna Under March 2026 Settlement Agreement

THOMSON REUTERS
·
Jul 16

Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech, Receives First Payment From Moderna Settlement Agreement and Announces Intent to Return Capital to Shareholders

GlobeNewswire
·
Jul 16

Arbutus Biopharma Shareholders Approve New 2026 Incentive Plan

TIPRANKS
·
May 28

Arbutus Biopharma shareholders approve 2026 omnibus share, incentive plan at annual meeting

Reuters
·
May 28

Arbutus Biopharma Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

Arbutus Biopharma Swings to Profit in Q1, Revenue Rises; Shares Up Pre-Bell

MT Newswires Live
·
May 13